جست‌وجوی استاد و پژوهشگر

Tsorng-Whay Panمشاهده پروفایل

استاد

• Computational Fluid Dynamics
• Numerical Analysis
• Particulate Flow Simulation
• +۳ مورد دیگر

Tsorng-Whay Pan is a Professor in the Department of Mathematics at the University of Houston. His research focuses on computational fluid dynamics, numerical analysis, and the simulation of particulate and blood cell motion in complex fluids. He has led or co-led multiple NSF-funded projects, including studies on viscoelastic fluid dynamics and blood flow modeling. Pan has advised numerous PhD students, including Jian Hao, Aixia Guo (co-supervised), and Ang Li. His work involves developing advanced methods like the distributed Lagrange multiplier/fictitious domain (DLM/FD) approach and has been supported by grants totaling over $1 million. Key research areas include fluid-particle interaction, blood cell motion in microchannels, and simulations of particulate flows in non-Newtonian fluids. His team has explored patterns in particle settling and fluidization, contributing to both theoretical and applied fluid dynamics. Pan organizes the Scientific Computing Seminar at UH and has co-organized international conferences such as the 2011 Workshop on Advances in Numerical Analysis. His academic contributions span over three decades, with a strong emphasis on interdisciplinary applications in engineering and biomedical systems.

Molly C. Fisherمشاهده پروفایل

دانشیار

• HIV-related Kidney Disease
• Hypertension Management
• Out-of-Office Blood Pressure Monitoring
• +۴ مورد دیگر

Molly C. Fisher, D.O., is an Associate Professor of Medicine in the Department of Medicine (Nephrology) at Albert Einstein College of Medicine, affiliated with Montefiore Medical Center. She holds board certifications in Internal Medicine and Nephrology, and serves as Director of the Montefiore Ambulatory Blood Pressure Monitoring Program and Nephrology Division Remote Blood Pressure Monitoring Program. Her clinical expertise includes managing resistant hypertension, out-of-office blood pressure monitoring, and HIV-associated kidney diseases. She leads the HIV-Kidney Disease Clinic at the AIDS Center for Positive Living. Education: Received her D.O. from University of Osteopathic Medicine and Health Sciences (2011), completed internal medicine residency at Stamford Hospital/Columbia University (2014), and nephrology fellowship at Montefiore/AECOM (2017). Professional activities include membership in the American Society of Nephrology and roles on the ASN In-Training Exam Committee. Research focuses on HIV-related kidney disease mechanisms, acute kidney injury in hospitalized patients (especially during the pandemic), and hypertension management. Key areas include identifying risk factors for chronic kidney disease in HIV patients, evaluating dietary interventions, and studying SARS-CoV-2's nephrological impacts. Her 15 most recent publications span HIV-nephrology intersections, COVID-19 kidney manifestations, and dialysis-related infections. Current work emphasizes translational research linking clinical outcomes with biomarkers and improving care equity through remote monitoring programs.

• Cellular Immunology
• Autoimmunity
• CD4+ T Cell Biology
• +۳ مورد دیگر

Ashley Milam is an Associate Professor in the Department of Biology at Saint Louis University within the College of Arts and Sciences. Her research focuses on cellular/molecular immunology and autoimmunity, particularly investigating how T cell affinity for self-antigens and metabolic pathways influence immune responses in diseases such as type 1 diabetes, colitis, multiple sclerosis, and bacterial infections. Education: B.S. in Biological Engineering (University of Missouri-Columbia), Ph.D. in Immunobiology (Yale University). Research interests include CD4+ T cell behavior, T cell receptor (TCR) signaling dynamics, and the role of cellular metabolism in immune regulation. Her work bridges basic immunology with translational models of autoimmune and infectious diseases. Recent studies explore how tonic TCR signaling impacts T follicular helper cell development and metabolic profiles, with implications for vaccine design and autoimmune therapies. Awards: No specific awards listed, though her work has been published in high-impact journals like Immunity, Nature Scientific Reports, and the Journal of Immunology. Advising/Grants: No named grants or advisees stated in provided materials. Her research is likely supported by institutional funding and collaborative grants. Labs/Teams: Affiliated with SLU's immunology research programs, though specific lab names not mentioned.

Weilan Yeمشاهده پروفایل

پژوهشگر ارشد

• Vascular Biology
• Molecular Oncology
• Angiogenesis
• +۳ مورد دیگر

Weilan Ye is a Principal Fellow in Molecular Oncology and Research Biology at Genentech, Inc., where she has worked for 30 years since 1995. Her research focuses on vascular biology and its role in diseases such as age-related macular degeneration, diabetic retinopathy, hereditary vascular disorders, and cancer. Ph.D. in Molecular, Cellular, Developmental Biology from the University of Pittsburgh (1995) B.S. in Biophysics from the University of Science and Technology of China (1988) Her work investigates how vascular alterations contribute to pathological conditions, particularly by manipulating molecular mechanisms that control vascular permeability and barrier function. She aims to develop therapies that modulate leukocyte trafficking and drug distribution in diseased tissues. Recent publications highlight her work on: Targeting MAP4K4 to enhance CD8 T cell immunity in tumors and viral infections Using EGFL7 antibodies to improve anti-VEGF efficacy and endothelial cell death in tumors Studying integrin α5β1 and LRP5 for anti-angiogenesis therapy in cancers and retinopathy Exploring Rap1-Rasip1 signaling in vascular junction stability and remodeling Weilan Ye also emphasizes postdoctoral mentorship as a critical component of her work at Genentech, fostering a collaborative environment that integrates dynamic thinking and innovative research.

• Vaccine Development
• Translational Medicine
• Nano Lipid Formulations
• +۳ مورد دیگر

Dr. Sharareh Eskandari is a Research Fellow at Griffith University's Institute for Biomedicine and Glycomics since 2016. She holds a PhD in Chemistry and Molecular Biosciences from the University of Queensland and has industrial experience as an R&D pharmacist. Her research focuses on translational vaccine development, lipid nanoparticle formulations, and adjuvant efficacy studies. Key projects include gonorrhoea vaccine trials and subunit peptide-protein vaccines for SARS-CoV-2. She contributed to a commercial streptococcal vaccine project with Olymvax Biopharmaceuticals (2016–2020) and participated in Phase III trials for the Sanofi Covid-19 vaccine. Awards include the 2021 Glycomics Early Career Research Excellence Award and a FAPESP travel fellowship (2018). Research Interests: Translational drug/vaccine development, nano lipid formulations (liposomes, SLN, NLCs), adjuvant characterisation, and immune response correlations. Peer-reviewed journals include Chemistry - A European Journal , Nanomedicine , and Advanced Drug Delivery Reviews . Professional Activities: Peer reviewer for journals like Journal of Materials Chemistry B and Biomaterials Advances . Member of the Australian Society for Microbiology and the Society for Mucosal Immunology.

Yuqing Huoمشاهده پروفایل

استاد

• Metabolic Pathways
• Inflammatory Pathways
• Vascular Biology
• +۴ مورد دیگر

Yuqing Huo is a **Professor** at **Baylor College of Medicine**, holding the Danny B. Jones Endowed Chair in Ophthalmology. He is also affiliated with the **Department of Medicine**, **Molecular and Cellular Biology**, and the **Cardiovascular Research Institute** at Baylor. He serves as a faculty member in the **Graduate School of Biomedical Sciences' Development, Disease Models and Therapeutics program**. **Education**: Dr. Huo earned a **PhD from Peking University (Beijing Medical University)** in 1998 and completed postdoctoral training at the **University of Virginia**. **Research Interests**: His work focuses on **metabolic and inflammatory pathways** in vascular diseases, including **cardiovascular diseases** (atherosclerosis, aneurysm, calcification) and **microvascular diseases** (retinopathy, stroke, Alzheimer’s-related vascular pathology). His lab employs **animal models**, omics analyses, and molecular/cellular assays to study **endothelial inflammation**, **leukocyte recruitment**, and **mesenchymal transition** in disease progression. **Grant Activities**: Current NIH-funded projects investigate **adenosine receptor 2A’s role in subretinal fibrosis**, **myeloid glycolysis in retinal angiogenesis**, and **PFKFB3-mediated atherogenesis**. He also leads an AHA-funded study on vascular smooth muscle cell metabolism in atherosclerosis. **Labs & Teams**: Principal investigator at the **Yuqing Huo Laboratory**, collaborating with cardiovascular and ophthalmology research groups at Baylor. His work bridges **translational research** and **therapeutic development** for vascular diseases.

Christoph A. Weberمشاهده پروفایل

استاد پژوهشی

• Biophysics
• Soft Matter Physics
• Active Matter
• +۳ مورد دیگر

Christoph A. Weber is a Group Leader at the Max Planck Institute for the Physics of Complex Systems and the Center for Systems Biology Dresden (CSBD). His research focuses on mesoscopic physics of life , including phase transitions in biological systems, intra-cellular organization mechanisms, and the physical principles underlying the origin of life. He holds a PhD in physics from Ludwig Maximilian University (LMU) Munich, where he studied under Prof. Erwin Frey. Prior to his current position, he conducted postdoctoral research at Harvard University and the Max Planck Institute for the Physics of Complex Systems. His work bridges biophysics, soft matter physics, and active matter, with a strong emphasis on theoretical modeling and interdisciplinary collaboration. Education : PhD in Physics (summa cum laude), LMU Munich (2013) Postdoc at Harvard University (2016–2018) Postdoc at MPIPKS Dresden (2013–2016) Research Highlights : Active droplet dynamics and protocell modeling Phase separation in biological systems (coacervates, condensates) Non-equilibrium phenomena in soft matter Origin-of-life studies via synthetic cell systems Collaborators and Labs : Prof. Olivier Dauchot (ESPCI Paris) Prof. Hugues Chaté (CEA Paris) Argonne National Laboratory (collaboration with Igor Aronson) Advising : He has mentored over 15 PhD, Master's, and undergraduate students in Dresden, Cambridge, and Munich, focusing on computational and theoretical approaches to active matter and biological physics.

H. Courtney Hodgesمشاهده پروفایل

دانشیار

• Epigenomics
• Disordered protein
• Chromatin and epigenetics
• +۵ مورد دیگر

H. Courtney Hodges is an Associate Professor at Baylor College of Medicine , with adjunct faculty status in the Department of Bioengineering at Rice University . She leads a lab focused on chromatin biology , transcription regulation , and cancer epigenetics , particularly the role of ATP-dependent chromatin remodelers like SWI/SNF (BAF) and disordered proteins in disease mechanisms. Department of Molecular and Cellular Biology , Baylor College of Medicine Center for Precision Environmental Health , Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center , Baylor College of Medicine Graduate Programs in Genetics/Genomics and Cancer/Cell Biology Adjunct Faculty , Rice University Department of Bioengineering Education: Ph.D. from U.C. Berkeley, Postdoctoral Fellowship at Stanford University School of Medicine. Her research interests include epigenomics, disordered protein interactions, chromatin dynamics, and translational applications in cancer therapy. She develops interdisciplinary methods combining epigenomic analysis , live-cell imaging , and chemical biology to study these systems. Recent publications highlight her work on SWI/SNF-chromatin interactions, disordered protein modules in transcription, and the therapeutic potential of epigenetic and chromatin-targeting drugs. Her lab contributes to understanding signal integration in gene expression , with implications for AML , bladder cancer , and developmental disorders . Scientific Awards: V Scholar Award Medical Research Award from Gabrielle's Angel Foundation for Cancer Research CPRIT Faculty Scholar Advising: Mentors graduate students and postdoctoral fellows , including Eric Smith , Courtney Chambers , and Sanjay Nagaraj . Her lab is affiliated with the Texas Medical Center , enabling collaboration with clinicians and researchers across institutions. She advocates for interdisciplinary training in wet-lab and computational epigenomics.

• Cancer Genomics
• Epigenetics
• Bioinformatics
• +۲ مورد دیگر

Timothy J Triche is Professor of Pathology at the Keck School of Medicine, University of Southern California. He directs research in cancer genomics, epigenetics, and bioinformatics, with emphasis on pediatric malignancies. His laboratory develops computational tools for genomic analysis and focuses on translating molecular discoveries into clinical diagnostics. Research spans pediatric acute myeloid leukemia, prostate cancer, and sarcoma biology, integrating multi-omics approaches. Key interests include liquid biopsy development, epigenetic dysregulation, and gene fusion mechanisms in oncogenesis. Publications demonstrate consistent focus on molecular diagnostics and bioinformatic innovation, with recent work advancing single-cell analysis methodologies and non-invasive cancer profiling. Earlier foundational studies established mechanisms of fusion oncoproteins in sarcomas.

Dustin Flanaganمشاهده پروفایل

پژوهشگر ارشد

• Stem Cell Biology
• Cell Competition
• Gastric Cancer
• +۷ مورد دیگر

Dr. Dustin Flanagan is a NHMRC Senior Research Fellow at the Monash Biomedicine Discovery Institute, leading the Cell Competition and Niche Signalling Laboratory in the Department of Biochemistry and Molecular Biology. His research focuses on stem cell biology, gastrointestinal cancers, and Wnt signaling pathways. He received his PhD in Gastrointestinal Biology from the University of Melbourne (2016) and conducted postdoctoral work at the CRUK Beatson Institute. His lab investigates stem cell regulation using genetically engineered mouse models (GEMMs) and 3D organoids, integrating advanced techniques like single-cell RNAseq and proteomics. He leads an active project (2022-2026) on gastric cancer mechanisms. Notable awards include the Metcalf Prize for Stem Cell Research (2023) and the Monash BDI Cancer Program MCR Shining Star award (2023). Education: Bachelor's with First-Class Honours, University of Melbourne (2008) PhD in Gastrointestinal Biology, University of Melbourne (2016) Research Interests: Stem cell dynamics, cell competition, intestinal and gastric tumorigenesis, Wnt signaling, and organoid modeling. His work bridges basic science and translational applications, aiming to develop therapies for gastrointestinal cancers. Recent Articles: Focus on hepatitis B virus infection modeling, NOTUM inhibition in colorectal cancer, and BCL-3’s role in DNA repair. These studies highlight his lab’s contributions to understanding cancer initiation and therapeutic targets. Grants & Awards: NHMRC Investigator Grant (2021) Metcalf Prize (2023) Monash BDI Award (2023) Labs/Teams: Directs the Cell Competition and Niche Signalling Lab, collaborating internationally on gastrointestinal cancer research.

Sushil Dhitalمشاهده پروفایل

دانشیار

• Food Science
• Chemical Engineering
• Plant Molecular Structures
• +۴ مورد دیگر

Sushil Dhital is an Associate Professor in the Department of Chemical Engineering at Monash University, where he has been since July 2019. His research focuses on the structure-property-function-health relationships of food and food ingredients, particularly leveraging interdisciplinary approaches from physics, chemistry, biology, and engineering. He is actively involved in editorial roles, serving as Editor for Carbohydrate Polymers and on the Editorial Boards of Food Hydrocolloids , Food Chemistry , and Bioactive Carbohydrates and Dietary Fibre . Additionally, he chairs the Australasian Grain Science Association (AGSA), which promotes collaboration among grain scientists, students, and industry professionals. Dr. Dhital holds a PhD in Food Technology from The University of Queensland (2011), an M.Tech in Food Technology from Tribhuvan University (2007), and an MBA from Tribhuvan University (2000). His academic journey includes a research fellowship at UQ, where he studied starch-plant cell wall interactions, before transitioning to Monash. His research interests are centered on plant molecular structures and their macroscopic implications for food, health, and product development. He employs in vitro digestion and fermentation models to investigate nutritional and processing functionalities. Key areas include starch granule structure, enzyme interactions, legume processing, and high-value ingredient extraction from by-products. His work contributes to UN Sustainable Development Goals related to sustainable food systems and improved health outcomes. Dr. Dhital leads multiple research projects as Primary Chief Investigator (PCI), such as the "Digital Twin of Plant Protein Extruder" (2024–2028) and "Walnut processing & by-product utilisation" (2024–present). He also collaborates globally on topics like legume and cereal processing, aiming to bridge nutritional gaps and enhance food sustainability.

• Materials Science & Engineering
• Interface of Biology & Engineering
• Mechanical & Manufacturing Engineering
• +۷ مورد دیگر

K. Jimmy Hsia is President Chair Professor in Mechanical Engineering at Nanyang Technological University (NTU) in Singapore, holding dual appointments in the School of Mechanical & Aerospace Engineering and School of Chemical and Biomedical Engineering. He currently serves as Vice President (Alumni & International Affairs) at NTU, a position he assumed in January 2020, after previously serving as Founding Dean of Graduate College since 2018. Dr. Hsia received his B.S. from Tsinghua University, M.S. from Beijing University of Aeronautics, and Ph.D. from MIT. His interdisciplinary research bridges engineering and biology with focus areas including material failure and fracture, soft robotics, micro-nanomechanics, cellular mechanics, and biomedical device development. His work appears in top journals including PNAS, Science Advances, Advanced Materials, and Nano Letters, with over 100 peer-reviewed publications and two Springer-published books. Hsia's research demonstrates a clear trajectory toward bio-integrated mechanical systems, with recent publications emphasizing the intersection of mechanics, biology, and advanced materials. His work on self-assembly mechanisms, organ-on-chip technology, and responsive materials represents cutting-edge interdisciplinary research with significant potential applications in biomedicine and soft robotics. Fellow of American Association for the Advancement of Science (AAAS) Fellow of American Society of Mechanical Engineers (ASME) Fellow of American Institute for Medical & Biological Engineering (AIMBE) US National Science Foundation (NSF) Research Initiation Award Max-Planck Society Scholarship Japan Society for Promotion of Science (JSPS) Fellowship Before joining NTU, Dr. Hsia held significant leadership positions including Vice Provost for International Programs and Strategy at Carnegie Mellon University, and W. Grafton and Lillian B. Wilkins Professor at University of Illinois at Urbana-Champaign where he served as Associate Dean of Graduate College and Associate Vice Chancellor for Research. His extensive administrative experience complements his research leadership as Founding Director of Nano and Bio Mechanics Program at NSF (2005-2007) and Founding co-Editor-in-Chief of Extreme Mechanics Letters.

Stéphanie Huguesمشاهده پروفایل

استاد

• Immunology
• Autoimmunity
• Cancer Immunotherapy
• +۵ مورد دیگر

Prof. Stéphanie Hugues is a Full Professor in the Department of Pathology and Immunology at the University of Geneva (UNIGE) Faculty of Medicine, and currently serves as Vice-Dean for Careers, Equality, Diversity, Inclusion, and Platforms. She holds a PhD in Immunology from the University of Nice (2002) and completed postdoctoral training at the Institut Curie (Paris) and INSERM. Her research focuses on immune tolerance mechanisms mediated by lymphatic endothelial cells (LECs), particularly their roles in autoimmunity and tumor immunity. Key contributions include elucidating MHC-II-dependent antigen presentation pathways in LECs and their impact on T cell regulation. Education: PhD in Immunology, University of Nice, 2002 Postdoctoral training at Institut Curie (2002–2006) and INSERM (2006–2007) Research and teaching position at UNIGE Faculty of Medicine (2007–2010) Research Interests: Mechanisms of immune tolerance via lymphatic endothelial cells Role of LECs in tumor immunity and metastasis inhibition MHC-II antigen presentation pathways in autoimmunity Circadian rhythms in cancer immunotherapy efficacy Recent work highlights the immunoregulatory functions of LECs in tumor microenvironments and their potential as targets for immunotherapy. Her group also investigates how autophagy and oxysterol metabolism modulate autoimmune responses. Scientific Awards: SNSF Fellowship (2010) Advising & Grants: Supervised over 10 doctoral and master’s students, including notable theses on tumor immunology and autoimmune mechanisms. Active in securing research grants focusing on lymphatic endothelium biology and translational immunology. Labs/Teams: Leads the Immunomodulation by Stromal Cells group at the Geneva Centre for Inflammation Research, collaborating with teams investigating T cell tolerance and tumor immunotherapy strategies.

• Cancer Biology
• Biochemistry
• Cell Biology
• +۳ مورد دیگر

Sonia Lain is a Professor at Karolinska Institutet's Department of Microbiology, Tumor and Cell Biology. She leads the 'Discovery and Elucidation of the mechanisms of Action of Tumour Selective Compunds' research group, part of the Division of Tumor Biology. Her work focuses on identifying molecules with therapeutic potential for cancer, particularly targeting DHODH (dihydroorotate dehydrogenase) inhibitors and p53 pathway activation. She holds a Docent degree from Karolinska Institutet (2012) and has been a professor since 2015. Her research integrates biochemistry, cell biology, and molecular oncology to develop novel cancer therapies. Research interests include tumor-selective compounds, pyrimidine metabolism, and the p53 signaling pathway. Her group investigates how DHODH inhibitors disrupt cancer cell proliferation while sparing normal cells. Key projects involve modulating nucleotide imbalance in tumors and understanding mechanisms of drug resistance. Publications highlight advancements in DHODH inhibitor mechanisms, metabolic effects of these compounds, and p53 activation strategies. The lab's work has been featured in journals like Nature Communications and Cell Chemical Biology . Collaborations with institutions like KTH and the University of Oxford underscore interdisciplinary approaches to drug discovery. No specific grants or awards are listed, but her group's research is supported by donations. She advises on lab activities but no formal student names are provided. The lab's future work includes optimizing DHODH inhibitors for clinical translation and exploring combination therapies.

Marianne Bronnerمشاهده پروفایل

استاد

• Cellular and Developmental Biology
• Evolutionary Biology
• Neuroscience
• +۵ مورد دیگر

Marianne Bronner is the Edward B. Lewis Professor of Biology and Director of the Beckman Institute at the California Institute of Technology. She holds a Sc.B. from Brown University (1975) and a Ph.D. from Johns Hopkins University (1979). Her career at Caltech spans roles including Ruddock Professor (2000-21), Distinguished Professor (2021), and Executive Officer (2013-16). Her research focuses on neural crest development, integrating molecular, cellular, and evolutionary approaches. Key areas include neural crest induction, placode formation, and their roles in craniofacial and sensory organ development. She explores evolutionary innovations like the vertebrate head by comparing lamprey, amphioxus, and jawed vertebrates. Her lab investigates mechanisms of cell migration, epigenetic regulation, and oncogenic processes linked to neural crest-derived cancers. Techniques employed include transcriptomics, CRISPR/Cas9, laser speckle imaging, and lineage tracing in chick, zebrafish, and lamprey models. Recent work highlights neural crest contributions to heart regeneration and neurofibromatosis modeling in zebrafish. The lab collaborates with the Caltech Women in STEM initiative and has pioneered tools for in vivo imaging and genetic manipulation. Lab Leadership: Bronner Lab at Caltech Key Projects: Neural crest gene regulatory networks, placode evolution, cancer biology Tools: Laser speckle imaging, CRISPR, lineage tracing Her work bridges developmental, evolutionary, and translational research, with implications for birth defects, cancer, and regenerative medicine.